EQRx’S Plan to Disrupt the Drug Market with CEO Melanie Nallicheri
By focusing on efficiency and leveraging technology, EQRx is aiming to “remake” medicine. CEO Melanie Nallicheri on her company’s plans to disrupt the drug industry by developing and delivering innovative new medicines at radically low prices.
